He spends 40 per cent of his time seeing patients in the hospital and 60 per cent in the laboratory developing new gene therapy treatments for complex diseases of the immune system.
Bobby says he couldn’t wish for more in his professional career, and that following scientific discoveries right through from the laboratory to being used to treat patients in the hospital is unique and rewarding.
Qualifications and training
Professor Gaspar's research spans many aspects of primary immunodeficiencies including:
- genetic diagnosis
- haematopoietic stem cell transplantation
- gene therapy